Selective induction of apoptosis in mutant p53 premalignant and malignant cancer cells by PRIMA-1 through the c-Jun-NH2-kinase pathway
about
Targeting p53 for Novel Anticancer Therapy.PRIMA-1(MET) induces death in soft-tissue sarcomas cell independent of p53.Activations of Both Extrinsic and Intrinsic Pathways in HCT 116 Human Colorectal Cancer Cells Contribute to Apoptosis through p53-Mediated ATM/Fas Signaling by Emilia sonchifolia Extract, a Folklore Medicinal Plant.The effect of adenovirus-mediated gene expression of FHIT in small cell lung cancer cells.Strategies for therapeutic targeting of the p53 pathway in cancer.Reactivation of mutant p53: molecular mechanisms and therapeutic potential.PRIMA-1 increases cisplatin sensitivity in chemoresistant ovarian cancer cells with p53 mutation: a requirement for Akt down-regulation.Chemopreventive effects of the p53-modulating agents CP-31398 and Prima-1 in tobacco carcinogen-induced lung tumorigenesis in A/J mice.Pharmacological activation of p53 in cancer cellsp53-based therapeutics for head and neck squamous cell carcinomaReversion of apoptotic resistance of TP53-mutated Burkitt lymphoma B-cells to spindle poisons by exogenous activation of JNK and p38 MAP kinases.HDAC inhibitor DWP0016 activates p53 transcription and acetylation to inhibit cell growth in U251 glioblastoma cells.Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis.MicroRNA-34a is an important component of PRIMA-1-induced apoptotic network in human lung cancer cells.Inhibition of the glutaredoxin and thioredoxin systems and ribonucleotide reductase by mutant p53-targeting compound APR-246
P2860
Q33655329-CBD15F85-D205-443C-8459-93797030E6AFQ35805485-2617723B-D191-4131-A68B-BB522FC7F4D2Q35830357-AE171A34-4D0B-46B5-8F3F-D6526AAC0263Q36025625-D0ED03CC-B5B9-46C1-AEDA-DD5E82B6D62DQ36430162-E7F94312-B3BF-46E3-ADC9-F00AA3F89E16Q36777373-DCC6CEC3-A288-4CE2-AE14-6821F56A194AQ36794233-32D01809-B67B-4F31-88AB-E6D45AAE190DQ37162374-0EABD064-C81F-4606-A7D1-1C58339ECAF9Q37191174-A9EE31A1-0967-4D34-8B4A-61FBA929D62FQ38102472-38BEE213-C3B4-467E-BC82-79FDFFCE3B05Q38999750-561146C9-28B2-45E2-A794-153B3CC29184Q39214706-67400E67-93D4-4220-8CA8-F3EB545C48AFQ40203796-4920AC20-F686-40C3-87DA-464F9DB52D70Q41583227-42D40256-D565-492A-9F51-6C5C7FDE8A86Q42860070-4193C135-BDA9-46D0-8E4C-14FF9DDADD90Q58714397-820871E6-AB30-4BA6-9DB7-35A6591FEE7E
P2860
Selective induction of apoptosis in mutant p53 premalignant and malignant cancer cells by PRIMA-1 through the c-Jun-NH2-kinase pathway
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Selective induction of apoptos ...... h the c-Jun-NH2-kinase pathway
@ast
Selective induction of apoptos ...... h the c-Jun-NH2-kinase pathway
@en
Selective induction of apoptos ...... h the c-Jun-NH2-kinase pathway
@en-gb
Selective induction of apoptos ...... h the c-Jun-NH2-kinase pathway
@nl
type
label
Selective induction of apoptos ...... h the c-Jun-NH2-kinase pathway
@ast
Selective induction of apoptos ...... h the c-Jun-NH2-kinase pathway
@en
Selective induction of apoptos ...... h the c-Jun-NH2-kinase pathway
@en-gb
Selective induction of apoptos ...... h the c-Jun-NH2-kinase pathway
@nl
prefLabel
Selective induction of apoptos ...... h the c-Jun-NH2-kinase pathway
@ast
Selective induction of apoptos ...... h the c-Jun-NH2-kinase pathway
@en
Selective induction of apoptos ...... h the c-Jun-NH2-kinase pathway
@en-gb
Selective induction of apoptos ...... h the c-Jun-NH2-kinase pathway
@nl
P921
P1476
Selective induction of apoptos ...... h the c-Jun-NH2-kinase pathway
@en
P2093
P2880
P304
P356
10.1158/1535-7163.MCT-04-0206
P407
P577
2005-06-01T00:00:00Z